Kura Oncology, Inc.KURANASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank93
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
13.50
↑ 392% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive declineElevated
Average
2.74
Historical baseline
PeriodValueYoY Change
202513.50-3.1%
202413.93-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-